PK101 / PMG Pharm 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PK101 / PMG Pharm
NCT04858659: A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis

Recruiting
3
354
RoW
PK101, PK101-002, PK101 placebo, PK101-002 placebo
PMG Pharm Co., Ltd
Knee Osteoarthritis
03/22
03/22

Download Options